(299b) QbD at the Boundary
AIChE Annual Meeting
2010
2010 Annual Meeting
Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
Quality-by-Design (QbD) Round Table Discussion Session: An Integrated and Science-Based Approach for Quality by Design (QbD) Implementation in Pharmaceutical Industry
Tuesday, November 9, 2010 - 12:45pm to 1:00pm
Quality Risk Assessments (QRA) for API and DP processes are mostly performed independently to examine the chemical or formulation processes themselves in terms of process risk and potential process control strategies. However, many of the process risks in a formulation process can be attributed to the properties of the API. In my talk, I will examine the potential application of QRA's to examine the overall risk across the API-DP boundary.